Results 11 to 20 of about 3,816 (188)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018 [PDF]

open access: yesRevista Panamericana de Salud Pública, 2020
Objective. To assess all the incidents of substandard, falsified and unregistered medicines in 2017 and 2018 in Latin America, determining the types of products affected, stages of the supply chain in which incidents were detected, quality deviations ...
Robin Rojas-Cortés
doaj   +3 more sources

Current scenario of spurious and substandard medicines in India: a systematic review. [PDF]

open access: yesIndian J Pharm Sci, 2015
Globally, every country is the victim of substandard or spurious drugs, which result in life threatening issues, financial loss of consumer and manufacturer and loss in trust on health system. The aim of this enumerative review was to probe the extent on poor quality drugs with their consequences on public health and the preventive measures taken by ...
Khan AN, Khar RK.
europepmc   +4 more sources

Substandard and falsified medicine screening technologies [PDF]

open access: yesAAPS Open, 2019
Substandard and falsified medicine screening technologies are invaluable tools for post-marketing surveillance of medicine quality, particularly in low- and middle-income countries.
Lukas Roth   +2 more
doaj   +2 more sources

Is this pill safe? Substandard medicines, mistaken solutions. [PDF]

open access: yesCMAJ, 2011
In most developing countries you can buy prescription medicines from street vendors and in corner stores, with no need for a doctor’s note and with only the untutored vendor’s suggestions as to dosage and side effects. You might well wonder about safety.
Fried M.
europepmc   +4 more sources

Medicine quality assessment in Nepal using semi randomised sampling and evaluation of a small scale dissolution test and portable Raman spectrometers [PDF]

open access: yesScientific Reports
Substandard and falsified medicines threaten global health and require reliable data and screening technologies to combat their spread. This study examined the quality of 241 samples containing azithromycin, cefixime, esomeprazole and losartan collected ...
Robin Schreiber   +6 more
doaj   +2 more sources

Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries

open access: yesFrontiers in Pharmacology, 2018
Substandard and falsified (SF) medicines have emerged as a global public health issue within the last two decades especially in low- and middle-income countries (LMICs). Serious consequences of this problem include a loss of trust and increased financial
Ulrike Holzgrabe, Holzgrabe Ulrike
exaly   +3 more sources

A systematic review of counterfeit and substandard medicines in field quality surveys

open access: yesIntegrated Pharmacy Research & Practice, 2014
Abdulaziz Fahad Abdulaziz Alghannam, Zoe Aslanpour, Sara Evans, Fabrizio Schifano Department of Pharmacy, University of Hertfordshire, Hatfield, Hertfordshire, United Kingdom Objectives: Counterfeit and substandard medicines pose a great threat to ...
Fabrizio Schifano
exaly   +2 more sources

Combatting substandard and falsified medicines: a view from Rwanda.

open access: yesPLoS Medicine, 2013
Agnes Binagwaho and colleagues describe Rwanda's experience of pharmacovigilance for malaria and tuberculosis, and call for a global treaty and leadership by the World Health Organization to address the global manufacture and trade in substandard and falsified medicines.
Agnes Binagwaho   +10 more
doaj   +5 more sources

Substandard and falsified medicine recalls in the legitimate supply chain: a systematic review of evidence [PDF]

open access: yesBMJ Open
Objectives To compare international substandard and falsified (SF) medicine recall trends from published research papers based on governmental databases, summarise the extent of the problem in the legitimate supply chain, and identify ways to manage the ...
Bernard D Naughton, Izabella Fryze
doaj   +2 more sources

Substandard medicines in resource‐poor settings: a problem that can no longer be ignored

open access: yesTropical Medicine and International Health, 2008
SummaryThe circulation of substandard medicines in the developing world is a serious clinical and public health concern. Problems include under or over concentration of ingredients, contamination, poor quality ingredients, poor stability and inadequate packaging. There are multiple causes.
J-M, Caudron   +5 more
exaly   +4 more sources

Home - About - Disclaimer - Privacy